Mission Statement

Castleman disease (CD) is a rare group of lymphoproliferative disorders that can be associated with systemic inflammation, immune dysregulation, and, in some cases, multi-organ dysfunction. Despite advances in understanding the disease, Castleman disease remains underdiagnosed and understudied, underscoring the need for collaborative research efforts, improved diagnostic tools, and educational initiatives to support better patient outcomes. Through the development of educational resources, we aim to advance the understanding, diagnosis, and management of Castleman disease.

The Team

Robert Ohgami, MD, PhD

Robert Ohgami, MD, PhD

David P. Ng, MD

David P. Ng, MD

Peyman Samghabadi, MD

Peyman Samghabadi, MD

Peng Li, MD, PhD

Peng Li, MD, PhD

Oscar Silva, MD, PhD

Oscar Silva, MD, PhD

Matthew Luo, MD Fellow

Matthew Luo, MD Fellow

Jingjing Zhang, MD, PhD

Jingjing Zhang, MD, PhD

Alnoor Akber, MD

Alnoor Akber, MD

Jyoti Kumar, MD, MS

Jyoti Kumar, MD, MS

Jacob R. Bledsoe, MD

Jacob R. Bledsoe, MD

Elizabeth Morgan, MD

Elizabeth Morgan, MD

Sarah J. Wu, MD, PhD

Sarah J. Wu, MD, PhD

Nick Spies, MD

Nick Spies, MD

Olga Winberg, MD

Olga Winberg, MD

Karen M. Chisholm, MD, PhD

Karen M. Chisholm, MD, PhD